IceCure, a biomedical company that develops minimally invasive therapies for women’s health, announced that it successfully removed benign breast cancer tumors from patients in a clinical trial conducted in Kamogowa, Japan. The company’s IceSense3 Cryoablation system is an ultrasound-guided procedure that penetrates the tumor and then removes it with extreme cold, thus replacing the need for surgical excision of the tumors. IceCure is headquartered in Caesarea, Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments